About
Windtree Therapeutics is a biopharmaceutical company developing treatments for cardiovascular and pulmonary conditions, with its lead candidate istaroxime in Phase 2 trials targeting acute heart failure and cardiogenic shock.
Explore Windtree Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.